Considering that T2D presents hyperglycemia and hyperinsulinemia, these findings raise the question whether high concentrations of insulin or glucose in vivo are directly responsible for the detrimental actions of NOX2 in endothelial and metabolic function. The gene discussed is CYBB; the disease is Hyperglycemia.